Recombinant IL13 (Cendakimab Biosimilar) antibody

Catalog No. ABIN7676011

The Human Monoclonal anti-IL13 (Cendakimab Biosimilar) antibody is suitable to detect IL13 (Cendakimab Biosimilar) in samples from Human. It has been validated for BLI, ELISA, FACS, Func and SPR.

Quick Overview for Recombinant IL13 (Cendakimab Biosimilar) antibody (ABIN7676011)

Target: IL13 (Cendakimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This IL13 (Cendakimab Biosimilar) antibody is un-conjugated

Application: Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-IL13 (Cendakimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-IL-13 Reference Antibody (cendakimab)

Characteristics: Anti-IL-13 Reference Antibody (cendakimab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for IL13 (Cendakimab Biosimilar)

Target: IL13 (Cendakimab Biosimilar)

Alternative Name: IL-13 (Cendakimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P35225